Meeting the clinical criteria is not the same as qualifying
Published 2026-08-20
Most coverage of the Medicare GLP-1 Bridge — ours included — leads with the clinical criteria, because that is what people can check about themselves: a BMI of 35, or 30 with heart failure, uncontrolled hypertension or chronic kidney disease, or 27 with prediabetes, a prior heart attack, a prior stroke or symptomatic peripheral artery disease. Those tiers are real and they are where most people start. But they are not the whole eligibility test, and the rules sitting outside them disqualify people who have already gotten their hopes up.
The first and broadest: if you have received a GLP-1 drug through your Part D plan at any point in 2026, you are not eligible for the Bridge — full stop, and regardless of why you received it. CMS's FAQ for plan sponsors is explicit that a beneficiary who has received a GLP-1 through Part D in CY 2026 does not qualify, even if they are now being prescribed a covered drug for weight management and otherwise meet every clinical criterion. The same holds if you are currently receiving one. The Bridge was deliberately designed to reach only people who would not otherwise have access, and prior access closes the door for the calendar year.
The second is diagnosis-based and works the opposite way from how people expect. A diagnosis of type 2 diabetes, moderate-to-severe obstructive sleep apnea, or MASH with moderate-to-advanced fibrosis makes you ineligible for the Bridge — not because you are too sick, but because those conditions are already coverable under Part D. Those requests belong with your plan, through its formulary exception process. CMS has said prior authorization requests attesting to any of those diagnoses will be denied, and that it may independently verify claims like a diabetes diagnosis against Medicare data.
The third catches a small but blindsided group: the type of Medicare plan you are in. Most Part D coverage qualifies, but people enrolled in private fee-for-service plans, section 1876 cost contract plans, section 1833 health care prepayment plans, PACE organizations, fallback plans, and religious fraternal benefit plans are not eligible — unless they also hold a standalone prescription drug plan. If you are in one of those arrangements, this is worth confirming before a provider visit rather than after.
The fourth is not about you at all: your prescriber must not appear on Medicare's Preclusion List for the drug to be covered. It affects very few people, but it is a genuine reason an otherwise clean authorization can fail, and it is not something a patient would ever think to check.
None of these are appealable in the ordinary sense, because none of them are clinical judgments — they are structural rules about who the demonstration was built to reach. The useful move is to check them first, in the order above, before investing a provider visit and documentation in a tier you may qualify for on paper but not in practice.